Eric Keller

InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA.

University of Washington functions as a College/University. The company is headquartered in Seattle, WA.

TD Securities, Inc. is a Canadian broker/dealer headquartered in Toronto, Ontario. The firm is a subsidiary of The Toronto-Dominion Bank (NYSE, TSE: TD). TD Securities provides a wide range of capital market products and services to corporate, government and institutional clients. Their services also include the underwriting and distribution of new debt and equity issues, providing advice on strategic acquisitions and divestitures and executing daily trading and investment needs. The firm’s equity group provides research coverage of various sectors. Their fixed-income group provides a full range of underwriting sales and trading products for Canadian, US and European debt issuers and investors.

Mediatrix SC, Inc. operates a radio station.

Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Part of Absence Soft LLC, Presagia Corp. is a cloud-based solutions provider that helps organizations solve complex health and business problems. The company is based in Montréal, Canada. Presagia Sports is the Canadian company's world-class athlete electronic health record system, leveraged by Olympic organizations, professional sports teams, performance arts organizations, sports medicine clinics, school districts, high schools, and universities to optimize how they manage athlete health. Presagia also provides cloud-based absence management solutions that enable employers to efficiently manage employee absence while complying with more than 500 federal, state, and local leave rules and 150 Canadian federal and provincial leave rules. Presagia integrates with customers' HR systems and automates leave processes, enabling organizations to increase efficiency, minimize absence, reduce cost, and improve compliance, while providing better customer service to employees. The company was founded in 1987 by David Glickman, and René Beaudoin has been the CEO of the company since 2021. Presagia was acquired by Absence Soft LLC on November 30, 2021.

Golub & Co. LLC (Golub) is a real estate firm founded in 1960 by Eugene Golub. The firm is headquartered in Chicago, IL.

Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut.

The Children's Medical Center Corp. operates as a non-profit hospital and research center. The company was founded in 1959 and is headquartered in Boston, MA.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

KensaGroup LLC (KensaGroup) is a private equity firm founded in 1999 by Bruce Ganem and Tony R. Eisenhut. The firm is headquartered in Ithaca, New York.

Mitsubishi Tanabe Pharma Development America, Inc. engages in the manufacture and distribution of pharmaceutical products. The firm address the needs of those with central nervous system disorders, people with amyotrophic lateral sclerosis, and other diseases that have high, unmet medical needs. The company is headquartered in Jersey City, NJ.

Luminopia, Inc. operates virtual reality content platform, which treats lazy eye. The company was founded by Scott Xiao, Alex Wendland and Dean A. Travers in and is headquartered in Aspen, CO.

Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY.

aMoon Ventures Y Sh Ltd (aMoon Ventures) is an venture capital firm founded in 2016 by Marius Nacht and Dr. Yair Schindel. The firm is headquartered in Israel.

Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA.

Suono Bio, Inc. develops therapeutics to the gastrointestinal tract which helps to cure diseases. The company was founded by Carl Schoellhammer, Robert S. Langer Jr., Amy W. Schulman, and Giovanni Traverso and is headquartered in Cambridge, MA.

Alivio Therapeutics, Inc. develops therapies to treat inflammatory disorders through targeted disease immunomodulation. The company was founded by Robert S. Langer, Jeffrey Karp, John LaMattima, Brian Leuthner, Bennett Shapiro, Eric Elenko, Joep Muijrers, and Stephen Muniz and is headquartered in Boston, MA.

Glympse Bio, Inc. develops modular nanoparticle sensors to create diagnostics for diseases. It uses engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. The company was founded in 2015 by Sangeeta Bhatia and Gabe A. Kwong and is headquartered in Cambridge, MA.

LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA.

Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford.

Celero Systems, Inc. is a life science company. It develops ingestible system to detect and reverse opioid overdose. The company was founded by Benjamin D. Pless, Carlo Giovanni Traverso, Robert S. Langer Jr., and Jeremy N. Ruskin and is headquartered in Lincoln, MA.

Trailhead Biosystems, Inc. develops cell therapies. Its program includes cancer immunotherapy, bone induction, neural fate space project, kidney and blood program. The company was founded by Jan Jensen in 2013 and is headquartered in Cleveland, OH.

Xenter, Inc. is a privately held, investor-backed company that has launched a wireless techmed ecosystem designed to provide transformative outcomes for physicians, healthcare professionals, provider organizations, and patients. Xenter is headquartered in Draper, UT and was formed in 2020. The company's trademarks include xenter, xenfi, xmd, xenfi-hub, xmd, and physical intelligence. The company was founded by Richard J. Linder and he has been the CEO since incorporation.

NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021.

Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet.

Syntis Bio, Inc. is a company that creates simple oral therapies and treatments targeting specific tissues through novel formulations. The company is based in Milton, MA. Rahul scaled the company by building a diverse and accomplished team to reach commercialization of the first-ever CRISPR product, diagnostic or therapeutic, to be authorized by the FDA. The company is committed to equity, excellence, and diversity, and is building a culture that supports its team to grow, take risks, and achieve individual goals. It was founded by Carlo Giovanni Traverso, Robert S. Langer, and Rahul K. Dhanda, who has been the CEO since incorporation.